Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical Practice
Issam S. Hamadeh, Donald C. Moore, Allison Martin, Allison Karabinos, Hailey Hill, Ami Ndiaye, Jordan Robinson, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Saad Z. Usmani
Topics & Concepts
DaratumumabMedicineClinical PracticeIntensive care medicineOncologyInternal medicineFamily medicineMultiple myelomaBortezomibMultiple Myeloma Research and TreatmentsCancer Immunotherapy and BiomarkersCAR-T cell therapy research